01—Abstract
Summary
Summary of the 10-Q filed August 4, 2025. Cited figures are marked; the original filing is the authoritative source.
CNH Industrial N.V. reported second-quarter 2025 total revenues of $4,711 milliona, down from $5,488 million a year earlier, with net sales of Industrial Activities at $4,021 million versus $4,803 million.
Net income attributable to CNH Industrial N.V. was $213 millionb for the quarter, compared with $399 million in the prior-year period, and diluted EPS was $0.17 versus $0.32. For the six months, net income attributable to CNH was $344 million ($0.27 diluted EPS) versus $767 million ($0.61) a year earlier. Adjusted EBIT of Industrial Activities fell to $224 million in the quarter from $502 million, with Agriculture adjusted EBIT at $263 million and Construction at $35 million, reflecting lower shipment volumes on decreased industry demand and continued dealer destocking.
The filing notes that prior-period figures were revised for an immaterial error related to highly inflationary accounting at the unconsolidated Türkiye affiliate TürkTraktör. Balance sheet and liquidity remained substantial: total assets were $43.7 billionc at June 30, 2025, total debt was $27.4 billion (of which Financial Services debt was $22.7 billion), and cash and cash equivalents were $2,512 million. Available liquidity, as defined by the company, totaled $9,266 million.
Operating cash flow for the six months was $934 milliond, compared with a $515 million outflow a year earlier, and the company paid $321 million in dividends. Management concluded that disclosure controls were not effective as of June 30, 2025 due to an unremediated material weakness related to the existence and completeness of raw material and work-in-process inventory, with full physical inventory counts planned for the fourth quarter of 2025.
The filing also discloses that the SEC staff notified the company on July 25, 2025 that its inquiry into revenue recognition and sales practices had concluded with no recommended enforcement action. The company also said it is evaluating the effects of the One Big Beautiful Bill Act, signed July 4, 2025, and expects to begin reflecting them in the third quarter of 2025.
02—Key points
Key Highlights
- Total revenues of $4,711 million in Q2 2025, down from $5,488 million; net sales of Industrial Activities of $4,021 million, down from $4,803 million
- Net income attributable to CNH Industrial N.V. of $213 million in Q2 2025 versus $399 million in Q2 2024; diluted EPS of $0.17 versus $0.32
- Adjusted EBIT of Industrial Activities of $224 million in Q2 2025 versus $502 million, with Agriculture at $263 million and Construction at $35 million
- Material weakness in internal control over inventory management remains unremediated; disclosure controls were concluded not effective as of June 30, 2025
- Operating cash flow of $934 million for the six months ended June 30, 2025, compared with a $515 million outflow in the prior-year period
- Total debt of $27.4 billion, of which $22.7 billion sits in Financial Services; available liquidity of $9,266 million
- SEC staff concluded its inquiry into revenue recognition and sales practices on July 25, 2025 and did not intend to recommend enforcement action
03—One dollar
04—Financials
Financial Highlights
Figures from 10-QQ2 FY2025filed August 4, 2025Financial Statements
Q2 FY2025 against Q2 FY2024
| Line item | Q2 FY2025Q2 FY2024 | Change |
|---|---|---|
| Revenue | $4.71B$5.49B | −14.2% |
| Cost of Revenue | $3.19B$3.70B | −13.8% |
| Gross Profit | $1.52B$1.79B | −14.9% |
| R&D Expenses | $218.00M$237.00M | −8.0% |
| SG&A Expenses | $478.00M$461.00M | +3.7% |
| Net Income | $217.00M$404.00M | −46.3% |
| EPS (Basic) | $0.17$0.32 | −46.9% |
| EPS (Diluted) | $0.17$0.32 | −46.9% |
| Shares Outstanding (Basic) | 1.25B1.26B | −0.5% |
| Shares Outstanding (Diluted) | 1.25B1.26B | −0.6% |
05—Questions
Frequently Asked Questions
Why did CNH's revenue and profit decline in the second quarter of 2025?
The filing attributes the decline in net sales mainly to lower shipment volumes driven by decreased industry demand and continued dealer destocking. Cost of goods sold rose as a percentage of Industrial Activities net sales to 79.4% from 77.1%, reflecting lower production volumes, partly offset by improved purchasing and manufacturing costs. Agriculture net sales fell 17.0% and Construction fell 13.1%.
What is the material weakness disclosed in this filing?
The company identified a material weakness in internal control over financial reporting related to inventory management, specifically deficiencies in the operating effectiveness of controls over the existence and completeness of raw material and work-in-process inventory. The weakness remained unremediated as of June 30, 2025. The filing states it has not resulted in misstatements, and remediation includes consultant support, full physical inventory counts planned for the fourth quarter of 2025, new standard operating procedures, and training.
How is CNH's debt structured between its industrial and financial businesses?
Total debt was $27,408 million at June 30, 2025, of which $5,230 million related to Industrial Activities and $22,744 million to Financial Services. The company reports Net Cash (Debt) of Industrial Activities at $(2,553) million, compared with $(1,727) million at December 31, 2024. Financial Services debt is generally repaid from collections of financing receivables, while Industrial Activities debt is repaid from operating cash flows.
What did the filing reveal about prior-period results?
The company corrected an immaterial error in its accounting for highly inflationary effects at its unconsolidated Türkiye affiliate, TürkTraktör. This overstated equity in income of unconsolidated subsidiaries by $34 million for the three months and $67 million for the six months ended June 30, 2024. Prior-period results were revised accordingly, with diluted EPS for the 2024 quarter moving from $0.34 to $0.32.
What is the potential tax impact of the One Big Beautiful Bill Act for CNH?
The OBBBA, signed on July 4, 2025, includes repeal of mandatory capitalization of research and development expenditures under IRC Section 174, reinstatement of full expensing beginning in 2025, extension of bonus depreciation, and revisions to U.S. international tax rules. The company is still evaluating the financial implications and expects to begin reflecting its effects in the third quarter of 2025.
06—Continue